carcinoembryonic
antigen
cystic
fibrosis
protein
blood
cystic
fibrosis
homozygote
heterozygote
carrier
carcinoembryonic
antigen
cea
activity
measured
radioimmunoassay
blood
cystic
fibrosis
cf
homozygote
heterozygote
carrier
cf
normal
healthy
control
patient
control
carcinoma
involving
gastrointestinal
organ
sample
also
screened
electrofocusing
cystic
fibrosis
protein
cfp
metabolic
marker
previously
shown
associated
cf
gene
significantly
increased
level
cea
activity
found
cfp
positive
group
however
one
exception
patient
control
marked
increase
cea
activity
cfp
negative
immunodiffusion
perchloric
acid
extract
cea
like
material
heterozygote
carrier
blood
indicated
cea
like
material
elevated
homozygote
heterozygote
cf
showed
partial
identity
two
separate
cea
preparation
obtained
colon
carcinoma
identical
either
b
h
blood
group
substance
glycoprotein
material
however
react
three
different
anti
cea
antiserum
finding
abnormally
increased
glycoprotein
cystic
fibrosis
taken
together
previous
report
demonstrating
abnormality
carbohydrate
portion
glycoprotein
found
various
exocrine
secretion
cf
suggests
primary
defect
disease
manifested
partly
defect
glycoprotein
metabolism
defect
may
result
abnormality
one
glycosyltransferases
possibly
caused
primary
defect
polyamine
metabolism
